UNSPSC 51393405: Theophylline

This classification denotes a bronchodilator and alkaloid with the molecular formula C7H8N4O2.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier C137DTR5RG, chemically known as 3,7-dihydro-1,3-dimethyl-1h-purine-2,6-dione but generally known as theophylline, which bears US NIH Compound Identifier 2153. European Medicines Agency schedules Theophylline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB15516MIG.

UNSPSC 51393405 Theophylline is a Commodity code that shows minimal alignment with recent state and local procurement activity. The code nominally describes a specific bronchodilator pharmaceutical, yet the two most recent opportunities tagged under it involve naloxone (a drug-reversal agent unrelated to theophylline therapy) and a Texas Health and Human Services Commission RFI exploring direct-to-manufacturer prescription programs for broader pharmacy benefit management—neither of which centers on theophylline procurement or use. Theophylline remains a legitimate pharmaceutical ingredient in asthma and COPD treatment protocols, but state and local buyers do not appear to be soliciting it as a discrete line item under this code in current procurement notices.

Geographic activity is limited to Florida and Texas based on the two available records. Seminole County, Florida issued IFB 60459723LAS on June 30, 2026, to procure naloxone and drug deactivation systems with a response deadline of July 26, 2023 (note the date inconsistency in the source record), while the Texas Health and Human Services Commission posted an RFI on April 3, 2026, to gather vendor information on direct pharmacy contracting models—an exploratory mechanism rather than a live solicitation. No recent opportunities targeting theophylline specifically are present in the available record. Given the code mismatch and absence of theophylline-specific solicitations, this code warrants continued monitoring but shows little current opportunity activity for vendors supplying theophylline products or services to state and local buyers.